Isofol Medical: The Curtain Opens for the Final Act
Research Update
2019-01-29
07:50
After a comprehensive review of the competitive landscape, we raise our forecast for market penetration. Our valuation model indicates a strong upside potential.
AN
Arvid Necander
Disclosures and disclaimers